ReIMAGINE webinar e-flyer 2020

Correcting 40 years of risk-stratification error in early prostate cancer

The game changer for prostate cancer diagnosis and prognosis

Join us for a series of informative and interactive webinars on the ReIMAGINE prostate cancer studies.

ReIMAGINE consists of multiple clinical studies jointly funded by the Medical Research Council and Cancer Research UK. For the first time biomarkers (blood, urine and tissue) will be combined with state-of-the-art imaging (MRI scans) to predict which prostate cancers are likely to progress over time and which will not.

Register to attend

Hear from some of the world's pre-eminent thought leaders in the area of prostate cancer diagnosis

Professor Mark Emberton

ReIMAGINE: The game changer in prostate
cancer diagnosis and prognosis

Thursday 10th September 2020, 3-4pm

Professor Hashim Ahmed

ReIMAGINE Prostate Cancer Risk Study
Monday 7th December 2020, 11am-12pm

Professor Caroline Moore

ReIMAGINE Prostate Cancer Screening Study

Thursday 11th March 2021,

Register to attend
Follow us on Twitter Follow us on Twitter
Visit our site Visit our site
For inquiries please email Saran Green, ReIMAGINE Patient and Public Involvement Coordinator at

Copyright © 2020 reIMAGINE, All rights reserved.

Copyright © 2020 ecancer All rights reserved.
UK charity number 1176307

You have received this because you are associated to 
ecancer. You may have also signed up to our newsletter on our website or other source.

If you do not want to receive future emails please click on the unsubscribe link.

Our mailing address is:

13 King Square Ave
Bristol, BS2 8HU
United Kingdom